Latest News and Press Releases

NeOnc (NASDAQ: NTHI) is entering one of the most significant periods after securing its second IND from the UAE

NeOnc Technologies Holdings (NASDAQ: NTHI) continues to build momentum as a neuro-oncology sector trailblazer

NeOnc (NASDAQ:NTHI) is developing therapies and delivery technologies targeting aggressive brain cancers and CNS-related conditions, and could be part of t

Wall St analysts are rating NeOnc Technologies (NASDAQ:NTHI) a “Buy”, as institutional investors and company insiders are buying

Insider conviction, late-stage clinical wins, and platform technologies are converging to reshape biotech/pharma valuations and patient outcomes.

Insiders are buying shares of $NTHI, $RIVN, $SRAD, $NWBI, and $FGBI